Standardisation is the key to the sustained, rapid and healthy development of stem cell‐based therapy

Abstract

AbstractBackgroundStem cell‐based therapy (SCT) is an important component of regenerative therapy that brings hope to many patients. After decades of development, SCT has made significant progress in the research of various diseases, and the market size has also expanded significantly. The transition of SCT from small‐scale, customized experiments to routine clinical practice requires the assistance of standards. Many countries and international organizations around the world have developed corresponding SCT standards, which have effectively promoted the further development of the SCT industry.MethodsWe conducted a comprehensive literature review to introduce the clinical application progress of SCT and focus on the development status of SCT standardization.ResultsWe first briefly introduced the types and characteristics of stem cells, and summarized the current clinical application and market development of SCT. Subsequently, we focused on the development status of SCT‐related standards as of now from three levels: the International Organization for Standardization (ISO), important international organizations, and national organizations. Finally, we provided perspectives and conclusions on the significance and challenges of SCT standardization.ConclusionsStandardization plays an important role in the sustained, rapid and healthy development of SCT.